Switchpoint Bio raises $5.3M pre seed
Announced 11 November 2026
◆ The Round
Switchpoint Bio raised $5.3M in pre seed funding, announced on 11 November 2026, led by Treehouse Delmar Investments. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
◆ About Switchpoint Bio
AI-powered epigenomics platform to monitor biological changes during treatment without repeated tissue biopsies. Switchpoint Bio is based in Finland and currently at pre seed stage, operating in Biotech.
◆ Investors
LeadTreehouse Delmar Investments
◆ Market context
This funding event is a citable node in Fusion42's market graph: it links Switchpoint Bio's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.
◆ Explore the market
◆ FAQ
How much did Switchpoint Bio raise?
Switchpoint Bio raised $5.3M in its pre-seed round, announced 2026-11-11.
Who invested in Switchpoint Bio's pre-seed round?
The round was led by Treehouse Delmar Investments.
What does Switchpoint Bio do?
AI-powered epigenomics platform to monitor biological changes during treatment without repeated tissue biopsies.
Verified 11 November 2026 · Sources: public filings